Acumen Pharmaceuticals Inc
ABOS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.2M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15.20 Million |
|---|---|
| Enterprise Value | $-12,678,034.00 |
| Earnings per Share | $-2 |
| Beta | 0.33 |
| Outstanding Shares | 72,321,459 |
Return
| Return on Equity | -181.55% |
|---|---|
| Return on Assets | -89.62% |
| Return on Invested Capital | -147.98% |
Valuation & Multiples
| P/E Ratio | -0.14 |
|---|---|
| PEG | 3.31 |
| Price to Sales | -0.24 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 140.87 |
| Enterprise Value to EBIT | 0.12 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.49 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 26, 2026
EPS Estimate
$-0.39
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.43
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 66.37% |
|---|---|
| Total Invested | $48,224▼ 99.96% |
| Investors Holding | 5▼ 94.00% |
About Acumen Pharmaceuticals Inc
2,021 employees
